"Poliovirus Vaccine, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
Concept/Terms
Poliovirus Vaccine, Oral- Poliovirus Vaccine, Oral
- Oral Poliovirus Vaccine
- Vaccine, Oral Poliovirus
- Sabin Vaccine
- Vaccine, Sabin
Below are MeSH descriptors whose meaning is more general than "Poliovirus Vaccine, Oral".
Below are MeSH descriptors whose meaning is more specific than "Poliovirus Vaccine, Oral".
This graph shows the total number of publications written about "Poliovirus Vaccine, Oral" by people in Harvard Catalyst Profiles by year, and whether "Poliovirus Vaccine, Oral" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 0 | 2 | 2 |
Below are the most recent publications written about "Poliovirus Vaccine, Oral" by people in Profiles.
-
Understanding the reasons for refusal of polio vaccine by families in Quetta Block, Pakistan. East Mediterr Health J. 2022 Jul 31; 28(7):498-505.
-
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social norms. Vaccine. 2022 06 15; 40(27):3752-3760.
-
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. Cochrane Database Syst Rev. 2019 12 05; 12:CD011260.
-
Lessons learned from the 2009-2010 H1N1 outbreak for the management of the 2013 silent polio outbreak. BMC Infect Dis. 2018 05 29; 18(1):241.
-
Feasibility of using global system for mobile communication (GSM)-based tracking for vaccinators to improve oral poliomyelitis vaccine campaign coverage in rural Pakistan. Vaccine. 2017 09 05; 35(37):5037-5042.
-
Placing Human Behavior at the Center of the Fight to Eradicate Polio: Lessons Learned and Their Application to Other Life-Saving Interventions. J Infect Dis. 2017 07 01; 216(suppl_1):S331-S336.
-
Immunisation coverage and its determinants among children aged 12-23 months in Atakumosa-west district, Osun State Nigeria: a cross-sectional study. BMC Public Health. 2016 08 30; 16:905.
-
Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel. BMC Med. 2016 06 23; 14(1):95.
-
Changing oral vaccine to inactivated polio vaccine might increase mortality. Lancet. 2016 Mar 12; 387(10023):1054-1055.
-
Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal. Vaccine. 2016 Feb 10; 34(7):933-41.